RU2522582C2 - Новые противомикробные средства - Google Patents

Новые противомикробные средства Download PDF

Info

Publication number
RU2522582C2
RU2522582C2 RU2011124795/04A RU2011124795A RU2522582C2 RU 2522582 C2 RU2522582 C2 RU 2522582C2 RU 2011124795/04 A RU2011124795/04 A RU 2011124795/04A RU 2011124795 A RU2011124795 A RU 2011124795A RU 2522582 C2 RU2522582 C2 RU 2522582C2
Authority
RU
Russia
Prior art keywords
heteroaryl
formula
compounds
alkyl
compound
Prior art date
Application number
RU2011124795/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2011124795A (ru
Inventor
Раджеш Джаин
Санджай Трехан
Джагаттаран Дас
Сандип КАНВАР
Ситарам Кумар МАГАДИ
Садхир Кумар ШАРМА
Original Assignee
Панацеа Биотек Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Панацеа Биотек Лтд. filed Critical Панацеа Биотек Лтд.
Publication of RU2011124795A publication Critical patent/RU2011124795A/ru
Application granted granted Critical
Publication of RU2522582C2 publication Critical patent/RU2522582C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU2011124795/04A 2008-11-20 2009-11-18 Новые противомикробные средства RU2522582C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2623/DEL/2008 2008-11-20
IN2623DE2008 2008-11-20
PCT/IN2009/000658 WO2010058423A2 (en) 2008-11-20 2009-11-18 Novel antimicrobials

Publications (2)

Publication Number Publication Date
RU2011124795A RU2011124795A (ru) 2012-12-27
RU2522582C2 true RU2522582C2 (ru) 2014-07-20

Family

ID=42198604

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011124795/04A RU2522582C2 (ru) 2008-11-20 2009-11-18 Новые противомикробные средства

Country Status (12)

Country Link
US (1) US8841306B2 (enExample)
EP (1) EP2367820B1 (enExample)
JP (1) JP5662940B2 (enExample)
KR (1) KR20110092309A (enExample)
CN (1) CN102224151A (enExample)
AR (1) AR074387A1 (enExample)
AU (1) AU2009318783A1 (enExample)
CA (1) CA2743971A1 (enExample)
MX (1) MX2011005365A (enExample)
RU (1) RU2522582C2 (enExample)
WO (1) WO2010058423A2 (enExample)
ZA (1) ZA201103978B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5855668B2 (ja) * 2010-10-13 2016-02-09 グラクソ グループ リミテッドGlaxo Group Limited 結核に対して有用な3−アミノ−ピラゾール誘導体
PT106651A (pt) * 2012-11-20 2014-05-20 Tecnimede Sociedade Tecnico Medicinal S A Quinolil hidrazonas para o tratamento de tuberculose e doenças relacionadas
CN103450173B (zh) * 2013-09-07 2015-06-03 吉首大学 吡咯酮-苯基-噁唑烷酮型化合物及其制法和用途
US10995097B2 (en) 2016-03-11 2021-05-04 The Board Of Trustees Of The University Of Illinois Small molecules active against gram-negative bacteria
US11274106B2 (en) 2017-06-23 2022-03-15 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and anticancer activity
US11896644B2 (en) * 2020-02-07 2024-02-13 University Of South Florida Inhibition of beta-arrestin oligomerization in tauopathy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA007490B1 (ru) * 2002-02-25 2006-10-27 Фармация Энд Апджон Компани N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667198B2 (en) 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
DK0718293T3 (da) 1993-09-06 2002-04-22 Fujisawa Pharmaceutical Co Cyclodepsipeptidforbindelse
DE69614847T2 (de) 1995-05-11 2002-04-04 Pharmacia & Upjohn Co., Kalamazoo Spirocyclische und bicyclische diazinyl- und carbazinyloxazolidinone
NZ315469A (en) 1995-09-01 2000-01-28 Upjohn Co Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
PL345162A1 (en) 1998-06-05 2001-12-03 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
JP2000204084A (ja) * 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
AU1379900A (en) 1998-11-17 2000-06-05 Bayer Aktiengesellschaft Novel substituted phenyloxazolidone derivatives
PT1181288E (pt) 1999-05-27 2003-12-31 Upjohn Co Oxazolidinonas biciclicas como agentes antibacterianos
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
CN1433413A (zh) 2000-06-05 2003-07-30 东亚制药株式会社 新的噁唑烷酮衍生物及其制备方法
JP2004501965A (ja) 2000-06-30 2004-01-22 ファルマシア・アンド・アップジョン・カンパニー 細菌感染を治療するための組成物および方法
DOP2002000333A (es) 2001-02-14 2002-09-30 Warner Lambert Co Derivados de acido isoftalico como inhibidores de metaloproteinasas de la matriz
ATE332299T1 (de) 2001-04-07 2006-07-15 Astrazeneca Ab Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika
GB0108793D0 (en) 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
US20040204477A1 (en) 2001-07-09 2004-10-14 Juergen Moll Interaction inhibitors of tcf-4 with beta-catenin
EP1409464A4 (en) 2001-07-16 2005-11-02 Ranbaxy Lab Ltd OXAZOLIDINONE DERIVATIVES AS POTENTIAL ANTIMICROBIALS
PL373802A1 (en) 2002-05-15 2005-09-19 Ranbaxy Laboratories Limited Polymorphic forms of phenyl oxazolidinone derivatives
WO2003097640A1 (en) 2002-05-22 2003-11-27 Orchid Chemicals & Pharmaceuticals Ltd. Oxazolidinone derivatives as antibacterial agents
WO2004009587A1 (en) 2002-07-22 2004-01-29 Orchid Chemicals & Pharmaceuticals Ltd Oxazolidinone derivatives as antibacterial agents
US20060293307A1 (en) 2002-07-29 2006-12-28 Anita Mehta Oxazolidinone derivatives as antimicrobials
EP1578734A1 (en) * 2002-08-22 2005-09-28 Orchid Chemicals and Pharmaceuticals Ltd Novel antibacterial agents
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
EP1565186B1 (en) * 2002-11-21 2006-11-02 Pharmacia & Upjohn Company LLC N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
GB0229526D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
GB0229518D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
CN1237056C (zh) * 2002-12-25 2006-01-18 中国科学院上海药物研究所 噁唑烷酮类化合物、其制备方法和用途
AU2003215861A1 (en) * 2003-04-07 2004-11-01 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
MXPA05010783A (es) 2003-04-09 2005-12-12 Pharmacia & Upjohn Co Llc Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos.
WO2004113329A1 (en) 2003-06-20 2004-12-29 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
WO2005003087A2 (en) 2003-07-01 2005-01-13 Orchid Chemicals And Pharmaceuticals Ltd. Oxazole derivatives as antibacterial agents
EP1646630A1 (en) 2003-07-02 2006-04-19 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
AU2004256084B2 (en) 2003-07-02 2007-10-18 Kyorin Pharmaceutical Co., Ltd. Oxazolidinone antibiotics and derivatives thereof
WO2005036169A2 (en) * 2003-10-03 2005-04-21 Cumbre Inc. Fluorescent probes for ribosomes and method of use
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2005082900A2 (en) 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone amidoximes as antibacterial agents
WO2005082897A1 (en) 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone antibacterial agents
US20080064689A1 (en) 2004-05-25 2008-03-13 Astrazeneca Ab 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
AU2005247671A1 (en) 2004-05-25 2005-12-08 Astrazeneca Ab 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as MAO inhibitors for the treatment of bacterial infections
WO2006035283A1 (en) 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2006043121A1 (en) 2004-10-20 2006-04-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2006109056A1 (en) 2005-04-12 2006-10-19 Vicore Pharma Ab New tricyclic angiotensin ii agonists
EP1745784A1 (en) 2005-06-27 2007-01-24 Ferrer Internacional, S.A. Oxazolidinone derivatives and use thereof as antibiotics
CA2614105A1 (en) 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
KR20070038236A (ko) 2005-10-05 2007-04-10 일동제약주식회사 신규 옥사졸리디논 포름 아미드 유도체 및 그 제조방법
JP2009523764A (ja) 2006-01-19 2009-06-25 ラボラトリオス・サルバト・ソシエダッド・アノニマ 抗菌活性を有するジカルボニル化合物
WO2007093904A1 (en) 2006-02-14 2007-08-23 Pfizer Products Inc. Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents
CN100406455C (zh) 2006-02-20 2008-07-30 中国科学院上海药物研究所 含三氮唑基的噁唑烷酮类化合物及其制备方法和用途
US8148362B2 (en) 2006-03-31 2012-04-03 Research Foundation Itsuu Laboratory Compound having heterocyclic ring
CA2692255A1 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use
CN101434584A (zh) * 2007-11-15 2009-05-20 中山大学 具有抗菌活性的手性噁唑烷酮类化合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA007490B1 (ru) * 2002-02-25 2006-10-27 Фармация Энд Апджон Компани N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств

Also Published As

Publication number Publication date
EP2367820B1 (en) 2016-09-21
JP5662940B2 (ja) 2015-02-04
WO2010058423A9 (en) 2011-04-28
AU2009318783A1 (en) 2011-06-23
US8841306B2 (en) 2014-09-23
MX2011005365A (es) 2011-06-24
US20110245258A1 (en) 2011-10-06
ZA201103978B (en) 2012-09-26
WO2010058423A3 (en) 2010-12-09
EP2367820A2 (en) 2011-09-28
EP2367820A4 (en) 2012-06-20
WO2010058423A2 (en) 2010-05-27
RU2011124795A (ru) 2012-12-27
CA2743971A1 (en) 2010-05-27
KR20110092309A (ko) 2011-08-17
JP2012509313A (ja) 2012-04-19
CN102224151A (zh) 2011-10-19
AR074387A1 (es) 2011-01-12

Similar Documents

Publication Publication Date Title
CN1046276C (zh) 取代羟基乙酰基哌嗪苯基唑烷酮酯及其用途
US6689779B2 (en) Oxazolidinone derivatives and a process for the preparation thereof
RU2414469C2 (ru) Новые производные оксазолидинона
DE602004004808T2 (de) Acyloxymethylcarbamatoxazolidinone und ihre Präparationen
US20020103186A1 (en) Oxazolidinone derivatives as antimicrobials disease
HUT75035A (en) 6-member nitrogen-containing heteroaryl-oxazolidinones, pharmaceutical compositions containing them and process for their preparation
RU2522582C2 (ru) Новые противомикробные средства
US8796465B2 (en) Process for the syntheses of triazoles
SK6997A3 (en) Cyclopentanopyridyl-oxazolidinones, which contain a heteroatom, process for producing them, their use and pharmaceutical composition containing such substances
EP1246810B1 (en) Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
KR20020067557A (ko) 설폭시민 관능기를 가지는 옥사졸리디논 및항미생물제로서의 그의 용도
WO2008143649A2 (en) Novel oxazolidinone compounds as antiinfective agents
US20040254162A1 (en) Oxazolidinone derivatives as antimicrobials
EP2766373B1 (en) Sila analogs of oxazolidinone derivatives and synthesis thereof
KR101653570B1 (ko) 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
EP1625124A1 (en) Oxazolidinone derivatives as antimicrobials
JP2000229978A (ja) オキサゾリジノン及び抗菌剤としてのそれらの使用
KR100980681B1 (ko) 디플루오로페닐 유도체를 갖는 신규한 옥사졸리디논 유도체또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 하는 항생제 조성물
KR100948345B1 (ko) 신규한 옥사졸리디논 유도체, 이의 제조방법 및 이를함유하는 의약 조성물
WO2008090570A1 (en) Novel antimicrobials
WO2009116090A2 (en) Novel antimicrobials
KR100674096B1 (ko) 피리미딘 고리를 포함하는 신규 옥사졸리디논 유도체와그의 제조방법
KR100629327B1 (ko) 신규 트리아졸릴메틸옥사졸리디논 유도체
WO2007004032A1 (en) Oxazolidiones containing cyclobutane as antibacterial agents

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20201119